Company intelligence / Profile preview

Silent Seeds

France

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Silent Seeds is a prominent cannabis genetics company and seed bank that emerged as the successor to the renowned Dinafem Seeds. Based in Europe, the company specializes in the research, development, and distribution of high-quality feminized and autoflowering cannabis seeds. They leverage decades of expertise in plant biotechnology and genetic selection to produce strains with specific cannabinoid profiles, including high-THC and CBD-rich varieties. Silent Seeds focuses on preserving elite clones and innovating through "Exotic" genetics, catering to both the recreational and emerging medical cannabis markets globally.

Therapeutic areas: PsychiatryNeurology
Modalities: Small moleculePlant-based therapyGenetic selection
Industry: Agriculture & AgTech

Partnerships

Booba (B-45 strain development)

Beyond the preview

Go deeper on Silent Seeds.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Silent Seeds.

Explore the full profile